Nicholette Zeliadt manages The Transmitters’s staff reporters and interns, and she commissions and edits news articles. She joined The Transmitter as news writer in 2014. Before that, she was a freelance writer and editor. Her work has appeared in The New York Times, Scientific American, Nature Medicine, Science and The Scientist.
Nicholette Zeliadt
Managing editor
The Transmitter
From this contributor
Leaving lasting marks with Tessa Montague
By
Nicholette Zeliadt
9 February 2024 | 7 min read
Spotted around the web: INSAR; cerebellar gene expression; pangenome
By
Jill Adams, Giorgia Guglielmi, Nicholette Zeliadt, Kristin Ozelli
12 May 2023 | 4 min read
Spotted around the web: Mapping histones; COVID-19 births; acetaminophen lawsuits
By
Jill Adams, Katharine Gammon, Peter Hess, Nicholette Zeliadt
4 November 2022 | 3 min read
New diagnostic code for PTEN syndrome may spur research
By
Nicholette Zeliadt
3 October 2022 | 4 min read
Education
- Ph.D. in environmental health, University of Minnesota
- B.A. in biochemistry, University of Iowa
Fellowships
- AAAS Mass Media Fellowship
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
By
Helena Kudiabor
15 April 2026 | 4 min read